Original Research

Published on 22 Feb 2021

CCR4, CCR8, and P2RY14 as Prognostic Factors in Head and Neck Squamous Cell Carcinoma Are Involved in the Remodeling of the Tumor Microenvironment

in Cancer Immunity and Immunotherapy

Liangliang Meng
Xiaoxi He
Quan Hong
Bo Qiao
Xiao Zhang
Bin Wu
Xiaobo Zhang
Yingtian Wei
Jing Li
Zhaoxiang Ye

Frontiers in Oncology

doi 10.3389/fonc.2021.618187

5,341 views
13 citations

Systematic Review

Published on 22 Feb 2021

TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation

in Cancer Immunity and Immunotherapy

Kui Zang
Liangliang Hui
Min Wang
Ying Huang
Xingxing Zhu
Bin Yao

Frontiers in Oncology

doi 10.3389/fonc.2021.579351

6,699 views
41 citations

Review

Published on 22 Feb 2021

The Efficacy and Safety of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease

in Cancer Immunity and Immunotherapy

Hui Tang
Jianfeng Zhou
Chunmei Bai

Frontiers in Oncology

doi 10.3389/fonc.2021.625872

7,946 views
39 citations

Original Research

Published on 19 Feb 2021

DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors

in Cancer Immunity and Immunotherapy

Yipeng Song
Jian Huang
Dandan Liang
Ying Hu
Beibei Mao
Qiujing Li
Huaibo Sun
Ying Yang
Jiao Zhang
Henghui Zhang

Frontiers in Oncology

doi 10.3389/fonc.2020.549777

7,814 views
29 citations

Mini Review

Published on 19 Feb 2021

Remodeling of Tumor Immune Microenvironment by Oncolytic Viruses

in Cancer Immunity and Immunotherapy

Bin Zhang
Xilei Wang
Ping Cheng

Frontiers in Oncology

doi 10.3389/fonc.2020.561372

5,416 views
26 citations

Original Research

Published on 19 Feb 2021

Prognostic Signatures Based on Thirteen Immune-Related Genes in Colorectal Cancer

in Cancer Immunity and Immunotherapy

Xiao-Bo Ma
Yuan-Yuan Xu
Meng-Xuan Zhu
Lu Wang

Frontiers in Oncology

doi 10.3389/fonc.2020.591739

5,565 views
19 citations

Original Research

Published on 16 Feb 2021

Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma

in Cancer Immunity and Immunotherapy

Yongkang Wang
Yinfeng Yang
Honglei Gao
Ting Ouyang
Luyao Zhang
Jili Hu
Sheng Hu
Hongxing Kan

Frontiers in Oncology

doi 10.3389/fonc.2020.566183

4,021 views
13 citations

Mini Review

Published on 16 Feb 2021

Synthetic TILs: Engineered Tumor-Infiltrating Lymphocytes With Improved Therapeutic Potential

in Cancer Immunity and Immunotherapy

Anaïs Jiménez-Reinoso
Daniel Nehme-Álvarez
Carmen Domínguez-Alonso
Luis Álvarez-Vallina

Frontiers in Oncology

doi 10.3389/fonc.2020.593848

11,446 views
22 citations

Mini Review

Published on 15 Feb 2021

Immunosuppression in Gliomas via PD-1/PD-L1 Axis and Adenosine Pathway

in Cancer Immunity and Immunotherapy

Thamiris Becker Scheffel
Nathália Grave
Pedro Vargas
Fernando Mendonça Diz
Liliana Rockenbach
Fernanda Bueno Morrone

Frontiers in Oncology

doi 10.3389/fonc.2020.617385

6,478 views
24 citations

Mini Review

Published on 11 Feb 2021

Biomarkers of Checkpoint Inhibitor Induced Immune-Related Adverse Events—A Comprehensive Review

in Cancer Immunity and Immunotherapy

Josefien W. Hommes
Rik J. Verheijden
Karijn P. M. Suijkerbuijk
Dörte Hamann

Frontiers in Oncology

doi 10.3389/fonc.2020.585311

16,194 views
99 citations

Case Report

Published on 09 Feb 2021

Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2− Breast Cancer Patient With High Tumor Mutational Burden

in Cancer Immunity and Immunotherapy

Rong Wang
Yuchen Yang
Wei-Wu Ye
Jianxing Xiang
Songan Chen
Wei-Bin Zou
Xiao-Jia Wang
Tianhui Chen
Wen-Ming Cao

Frontiers in Oncology

doi 10.3389/fonc.2020.588080

3,558 views
9 citations

Original Research

Published on 08 Feb 2021

Screening and Identification of Four Prognostic Genes Related to Immune Infiltration and G-Protein Coupled Receptors Pathway in Lung Adenocarcinoma

in Cancer Immunity and Immunotherapy

Yan Wang
Liwei Qiu
Yu Chen
Xia Zhang
Peng Yang
Feng Xu

Frontiers in Oncology

doi 10.3389/fonc.2020.622251

4,300 views
6 citations

Review

Published on 08 Feb 2021

Immune Microenvironment: New Insight for Familial Adenomatous Polyposis

in Cancer Immunity and Immunotherapy

Jun Yang
Zhengqi Wen
Wenliang Li
Xianghua Sun
Junrui Ma
Xueke She
Hongbin Zhang
Changling Tu
Guoqiang Wang
Depei Huang

Frontiers in Oncology

doi 10.3389/fonc.2021.570241

9,732 views
9 citations

Case Report

Published on 05 Feb 2021

Case Report: Neoadjuvant PD-1 Blockade Plus Concurrent Chemoradiotherapy in Unresectable Locally Advanced Gastric Cancer Patients

in Cancer Immunity and Immunotherapy

Jia Wei
Xiaofeng Lu
Qin Liu
Lin Li
Song Liu
Fangcen Liu
Yao Fu
Xiangshan Fan
Yang Yang
Chuang Qi

Frontiers in Oncology

doi 10.3389/fonc.2020.554040

4,235 views
6 citations

Review

Published on 03 Feb 2021

Enhancing the Efficacy of Tumor Vaccines Based on Immune Evasion Mechanisms

in Cancer Immunity and Immunotherapy

Jianyu Chen
Honghao Zhang
Lijuan Zhou
Yuxing Hu
Meifang Li
Yanjie He
Yuhua Li

Frontiers in Oncology

doi 10.3389/fonc.2020.584367

4,217 views
11 citations

Correction

Published on 03 Feb 2021

Corrigendum: Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity

in Cancer Immunity and Immunotherapy

Johannes Sam
Sara Colombetti
Tanja Fauti
Andreas Roller
Marlene Biehl
Linda Fahrni
Valeria Nicolini
Mario Perro
Tapan Nayak
Esther Bommer

Frontiers in Oncology

doi 10.3389/fonc.2021.650149

1,525 views

Navigation group

Articles

CCR4, CCR8, and P2RY14 as Prognostic Factors in Head and Neck Squamous Cell Carcinoma Are Involved in the Remodeling of the Tumor Microenvironment

TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation

The Efficacy and Safety of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease

DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors

Remodeling of Tumor Immune Microenvironment by Oncolytic Viruses

Prognostic Signatures Based on Thirteen Immune-Related Genes in Colorectal Cancer

Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma

Synthetic TILs: Engineered Tumor-Infiltrating Lymphocytes With Improved Therapeutic Potential

Immunosuppression in Gliomas via PD-1/PD-L1 Axis and Adenosine Pathway

Biomarkers of Checkpoint Inhibitor Induced Immune-Related Adverse Events—A Comprehensive Review

Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2− Breast Cancer Patient With High Tumor Mutational Burden

Screening and Identification of Four Prognostic Genes Related to Immune Infiltration and G-Protein Coupled Receptors Pathway in Lung Adenocarcinoma

Immune Microenvironment: New Insight for Familial Adenomatous Polyposis

Case Report: Neoadjuvant PD-1 Blockade Plus Concurrent Chemoradiotherapy in Unresectable Locally Advanced Gastric Cancer Patients

Enhancing the Efficacy of Tumor Vaccines Based on Immune Evasion Mechanisms

Corrigendum: Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity